NCT00991848View on ClinicalTrials.gov

Lidocaine on Manifestations of Fibromyalgia

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

September 30, 2008

Conditions
FibromyalgiaChronic Pain
Interventions
DRUG

Lidocaine

received 240 mg lidocaine diluted in 125 mL 0.9% saline.

Trial Locations (1)

Unknown

Federal University of São Paulo, São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT00991848 - Lidocaine on Manifestations of Fibromyalgia | Biotech Hunter | Biotech Hunter